Trial Details

COMPLETED
Basic Information
Clinical ID c4734
Identifier NCT00055367
Trial Title Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: natalizumab
Participant Information
Sponsor Biogen
City Los Angeles
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2002-04
Primary Completion Date 2004-05
Completion Date 2004-05